Bone mineral density in familial Mediterranean fever

Neslihan Berkdemir Siverekli1, Ozlem Sahin, Soner Senel

  • 1Faculty of Medicine, Department of Rheumatology, Cumhuriyet University, 58141 Sivas, Turkey.

Insights

Familial Mediterranean fever (FMF) patients show no significant bone loss compared to healthy individuals. However, those without a family history of FMF exhibited lower bone mineral density, warranting further investigation.

Area of Science:

  • Rheumatology
  • Genetics
  • Bone Metabolism

Background:

  • Familial Mediterranean fever (FMF) is a genetic autoinflammatory disorder.
  • Bone mineral density (BMD) alterations may occur in chronic inflammatory conditions.
  • The impact of FMF on BMD and associated genetic/clinical factors requires clarification.

Purpose of the Study:

  • To evaluate bone mineral density (BMD) in patients with familial Mediterranean fever (FMF).
  • To investigate the influence of genetic factors, FMF family history, and clinical attack types on BMD in FMF patients.

Main Methods:

  • Dual-energy X-ray absorptiometry (DEXA) was used to measure BMD.
  • Study included 44 attack-free FMF patients and 36 healthy controls.
  • BMD was assessed at the lumbar spine and proximal femur.

Main Results:

  • No significant difference in BMD was observed between FMF patients and controls.
  • Patients with a negative FMF family history had significantly lower femoral neck and total femur BMD compared to those with a positive family history.
  • Mutation characteristics and attack types did not significantly affect BMD in FMF patients.

Conclusions:

  • Bone loss in FMF patients is comparable to that of healthy individuals.
  • Reduced BMD in FMF patients without a family history suggests a potential genetic predisposition or risk factor.
  • Further research with larger cohorts is recommended to explore osteoporosis risk factors related to family history in FMF.